5 December 2024 in The Cleft Palate Craniofacial Journal
Objective: Autologous rib harvest with manual framework production is the current gold standard for microtia reconstruction. Recent clinical success with implantation of cadaveric costal cartilage grafts opens the possibility of point of care auricular framework production. This paper assesses the feasibility and efficiency of 3D milling of cadaveric costal cartilage for auricular framework production. Design: A Nagata/Firmin style auricular framework was manually carved en bloc out of soap and 3D scanned to design a milling toolpath on a desktop 3-axis computer numerical control (CNC) machine. An en bloc framework was then milled from cadaveric costal cartilage. Time to mill a complete framework was recorded. The dimensional/volumetric analyses were performed. Main Outcome Measure(s): The main outcome measures were total time to mill a complete auricular framework out of cadaveric cartilage and dimensional/volumetric comparisons to the model ear. Results: Total milling time for the cartilage framework was approximately 7 min. Finalizing steps took an extra 20 min. Total time to produce a final framework ready for implantation was approximately 27 min, compared to the traditional 1-2 h by manual carving. All dimensional comparisons were within 2 mm to the manually carved model. Volumetric analysis showed 71% similarity. Conclusions: En bloc cadaveric costal cartilage framework milling is both feasible and efficient. 3D milling significantly reduces framework production time and allows for accurate reconstruction of the complex ear geometry, which can translate to cost savings, optimized patient safety, and potential for patient-specific reconstruction. The next step toward achieving clinical application is ensuring framework sterility.
14 January 2026 in Aesthetic Surgery Journal Open Forum
Acellular dermal matrix (ADM) is widely used in implant-based breast reconstruction for implant stabilization, soft-tissue augmentation, and reduced capsular contracture, although its use in this setting remains off-label. Conventional approaches involve placing a single ADM layer during first-stage tissue expander placement. The authors present a novel approach that utilizes ADM in both stages of tissue expander/implant-based breast reconstruction, creating a bilayer ADM construct to enhance soft tissue support. This study aimed to describe the technique of serially stacked ADM in implant-based breast reconstruction and assess its preliminary safety profile. A retrospective review was conducted of all patients who received bilayer ADM in expander/implant-based breast reconstruction by a single surgeon between July 2020 and May 2024. Patient demographics, operative details, time between stages, follow-up duration, and major complications were assessed. Nineteen patients were included in this study. The mean age was 46 ± 8.6 years, and the mean BMI was 21.6 ± 2.85 kg/m2. Two patients had a history of radiation therapy. Seventeen reconstructions were prepectoral, and 2 were subpectoral. The average time from expander placement to implant exchange was 180 days. The average follow-up after the second stage was 10.8 months. No patients required reoperation or hospital readmission after either stage, and no major intraoperative or postoperative complications were reported. Preliminary findings from this cohort suggest that stacked ADM may be considered a safe and effective adjunct for enhancing soft tissue coverage in implant-based breast reconstruction. Larger prospective studies are needed to confirm these early results. Level of Evidence: 4 (Therapeutic)